nodes	percent_of_prediction	percent_of_DWPC	metapath
Trospium—Vulvovaginal pain—Capecitabine—esophageal cancer	0.0507	0.0648	CcSEcCtD
Trospium—Vaginal pain—Capecitabine—esophageal cancer	0.0507	0.0648	CcSEcCtD
Trospium—Hypertensive crisis—Capecitabine—esophageal cancer	0.0247	0.0316	CcSEcCtD
Trospium—Coronary artery disease—Cisplatin—esophageal cancer	0.0235	0.0301	CcSEcCtD
Trospium—Pain in jaw—Capecitabine—esophageal cancer	0.021	0.0269	CcSEcCtD
Trospium—Hoarseness—Capecitabine—esophageal cancer	0.0156	0.0199	CcSEcCtD
Trospium—Infection—Carboplatin—esophageal cancer	0.0112	0.0144	CcSEcCtD
Trospium—Supraventricular tachycardia—Capecitabine—esophageal cancer	0.0105	0.0134	CcSEcCtD
Trospium—Hyperuricaemia—Cisplatin—esophageal cancer	0.01	0.0128	CcSEcCtD
Trospium—Blood uric acid increased—Cisplatin—esophageal cancer	0.00948	0.0121	CcSEcCtD
Trospium—Rash erythematous—Capecitabine—esophageal cancer	0.00896	0.0115	CcSEcCtD
Trospium—Fluid retention—Cisplatin—esophageal cancer	0.00883	0.0113	CcSEcCtD
Trospium—Dysphonia—Capecitabine—esophageal cancer	0.00834	0.0107	CcSEcCtD
Trospium—Influenza like illness—Capecitabine—esophageal cancer	0.00666	0.00852	CcSEcCtD
Trospium—Fluid retention—Capecitabine—esophageal cancer	0.00651	0.00833	CcSEcCtD
Trospium—Dry eye—Capecitabine—esophageal cancer	0.00634	0.0081	CcSEcCtD
Trospium—Mouth ulceration—Capecitabine—esophageal cancer	0.0062	0.00793	CcSEcCtD
Trospium—Orthostatic hypotension—Cisplatin—esophageal cancer	0.00617	0.00789	CcSEcCtD
Trospium—Breast disorder—Cisplatin—esophageal cancer	0.0061	0.00781	CcSEcCtD
Trospium—Cramp muscle—Cisplatin—esophageal cancer	0.00608	0.00778	CcSEcCtD
Trospium—Nasopharyngitis—Cisplatin—esophageal cancer	0.00604	0.00772	CcSEcCtD
Trospium—Abnormal vision—Capecitabine—esophageal cancer	0.00598	0.00765	CcSEcCtD
Trospium—Ear pain—Capecitabine—esophageal cancer	0.00584	0.00746	CcSEcCtD
Trospium—Sweating increased—Cisplatin—esophageal cancer	0.00569	0.00727	CcSEcCtD
Trospium—Abdominal discomfort—Cisplatin—esophageal cancer	0.0056	0.00716	CcSEcCtD
Trospium—Eye pain—Capecitabine—esophageal cancer	0.00552	0.00705	CcSEcCtD
Trospium—Hyperuricaemia—Methotrexate—esophageal cancer	0.0055	0.00704	CcSEcCtD
Trospium—Hot flush—Capecitabine—esophageal cancer	0.00532	0.00681	CcSEcCtD
Trospium—Menopausal symptoms—Capecitabine—esophageal cancer	0.00528	0.00675	CcSEcCtD
Trospium—Thirst—Capecitabine—esophageal cancer	0.00523	0.00669	CcSEcCtD
Trospium—Blood uric acid increased—Methotrexate—esophageal cancer	0.0052	0.00665	CcSEcCtD
Trospium—Stomatitis—Cisplatin—esophageal cancer	0.00507	0.00649	CcSEcCtD
Trospium—Migraine—Capecitabine—esophageal cancer	0.0049	0.00627	CcSEcCtD
Trospium—Urinary retention—Capecitabine—esophageal cancer	0.00473	0.00605	CcSEcCtD
Trospium—Bladder pain—Methotrexate—esophageal cancer	0.00462	0.0059	CcSEcCtD
Trospium—Mouth ulceration—Methotrexate—esophageal cancer	0.00462	0.0059	CcSEcCtD
Trospium—Urinary tract disorder—Cisplatin—esophageal cancer	0.00461	0.0059	CcSEcCtD
Trospium—Connective tissue disorder—Cisplatin—esophageal cancer	0.00459	0.00587	CcSEcCtD
Trospium—Urethral disorder—Cisplatin—esophageal cancer	0.00458	0.00586	CcSEcCtD
Trospium—Dry skin—Capecitabine—esophageal cancer	0.00456	0.00584	CcSEcCtD
Trospium—Orthostatic hypotension—Capecitabine—esophageal cancer	0.00455	0.00582	CcSEcCtD
Trospium—Abdominal pain upper—Capecitabine—esophageal cancer	0.00455	0.00582	CcSEcCtD
Trospium—Visual impairment—Cisplatin—esophageal cancer	0.0045	0.00576	CcSEcCtD
Trospium—Breast disorder—Capecitabine—esophageal cancer	0.0045	0.00575	CcSEcCtD
Trospium—Nasopharyngitis—Capecitabine—esophageal cancer	0.00445	0.00569	CcSEcCtD
Trospium—Gastritis—Capecitabine—esophageal cancer	0.00441	0.00564	CcSEcCtD
Trospium—Eye disorder—Cisplatin—esophageal cancer	0.00437	0.00558	CcSEcCtD
Trospium—Lymphadenopathy—Methotrexate—esophageal cancer	0.00434	0.00556	CcSEcCtD
Trospium—Cardiac disorder—Cisplatin—esophageal cancer	0.00434	0.00555	CcSEcCtD
Trospium—Flushing—Cisplatin—esophageal cancer	0.00434	0.00555	CcSEcCtD
Trospium—Abdominal distension—Capecitabine—esophageal cancer	0.00433	0.00554	CcSEcCtD
Trospium—Influenza—Capecitabine—esophageal cancer	0.0043	0.0055	CcSEcCtD
Trospium—Mediastinal disorder—Cisplatin—esophageal cancer	0.00421	0.00539	CcSEcCtD
Trospium—Sweating increased—Capecitabine—esophageal cancer	0.00419	0.00536	CcSEcCtD
Trospium—Angina pectoris—Capecitabine—esophageal cancer	0.00419	0.00536	CcSEcCtD
Trospium—Abdominal discomfort—Capecitabine—esophageal cancer	0.00413	0.00528	CcSEcCtD
Trospium—Malnutrition—Cisplatin—esophageal cancer	0.00407	0.0052	CcSEcCtD
Trospium—Dysuria—Capecitabine—esophageal cancer	0.00402	0.00515	CcSEcCtD
Trospium—Flatulence—Cisplatin—esophageal cancer	0.00401	0.00513	CcSEcCtD
Trospium—Photosensitivity reaction—Capecitabine—esophageal cancer	0.00393	0.00502	CcSEcCtD
Trospium—Weight increased—Capecitabine—esophageal cancer	0.00392	0.00501	CcSEcCtD
Trospium—Muscle spasms—Cisplatin—esophageal cancer	0.00391	0.005	CcSEcCtD
Trospium—Infestation—Capecitabine—esophageal cancer	0.00384	0.00491	CcSEcCtD
Trospium—Infestation NOS—Capecitabine—esophageal cancer	0.00384	0.00491	CcSEcCtD
Trospium—Vision blurred—Cisplatin—esophageal cancer	0.00383	0.0049	CcSEcCtD
Trospium—Stevens-Johnson syndrome—Capecitabine—esophageal cancer	0.0038	0.00487	CcSEcCtD
Trospium—Stomatitis—Capecitabine—esophageal cancer	0.00374	0.00478	CcSEcCtD
Trospium—Urinary tract infection—Capecitabine—esophageal cancer	0.00373	0.00477	CcSEcCtD
Trospium—Haematuria—Capecitabine—esophageal cancer	0.00366	0.00468	CcSEcCtD
Trospium—Rhinitis—Capecitabine—esophageal cancer	0.00345	0.00442	CcSEcCtD
Trospium—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00344	0.0044	CcSEcCtD
Trospium—Urinary tract disorder—Capecitabine—esophageal cancer	0.0034	0.00435	CcSEcCtD
Trospium—Oedema peripheral—Capecitabine—esophageal cancer	0.00339	0.00434	CcSEcCtD
Trospium—Connective tissue disorder—Capecitabine—esophageal cancer	0.00338	0.00433	CcSEcCtD
Trospium—Urethral disorder—Capecitabine—esophageal cancer	0.00338	0.00432	CcSEcCtD
Trospium—Breast disorder—Methotrexate—esophageal cancer	0.00335	0.00428	CcSEcCtD
Trospium—Oedema—Cisplatin—esophageal cancer	0.00332	0.00425	CcSEcCtD
Trospium—Anaphylactic shock—Cisplatin—esophageal cancer	0.00332	0.00425	CcSEcCtD
Trospium—Visual impairment—Capecitabine—esophageal cancer	0.00332	0.00425	CcSEcCtD
Trospium—Infection—Cisplatin—esophageal cancer	0.0033	0.00422	CcSEcCtD
Trospium—Erythema multiforme—Capecitabine—esophageal cancer	0.00326	0.00417	CcSEcCtD
Trospium—Nervous system disorder—Cisplatin—esophageal cancer	0.00326	0.00416	CcSEcCtD
Trospium—Tachycardia—Cisplatin—esophageal cancer	0.00324	0.00414	CcSEcCtD
Trospium—Skin disorder—Cisplatin—esophageal cancer	0.00322	0.00412	CcSEcCtD
Trospium—Eye disorder—Capecitabine—esophageal cancer	0.00322	0.00412	CcSEcCtD
Trospium—Hyperhidrosis—Cisplatin—esophageal cancer	0.00321	0.0041	CcSEcCtD
Trospium—Flushing—Capecitabine—esophageal cancer	0.0032	0.00409	CcSEcCtD
Trospium—Cardiac disorder—Capecitabine—esophageal cancer	0.0032	0.00409	CcSEcCtD
Trospium—Angiopathy—Capecitabine—esophageal cancer	0.00313	0.004	CcSEcCtD
Trospium—Mediastinal disorder—Capecitabine—esophageal cancer	0.0031	0.00397	CcSEcCtD
Trospium—Abdominal discomfort—Methotrexate—esophageal cancer	0.00307	0.00393	CcSEcCtD
Trospium—Malnutrition—Capecitabine—esophageal cancer	0.003	0.00383	CcSEcCtD
Trospium—Dysuria—Methotrexate—esophageal cancer	0.003	0.00383	CcSEcCtD
Trospium—Flatulence—Capecitabine—esophageal cancer	0.00295	0.00378	CcSEcCtD
Trospium—Dysgeusia—Capecitabine—esophageal cancer	0.00294	0.00376	CcSEcCtD
Trospium—Photosensitivity reaction—Methotrexate—esophageal cancer	0.00292	0.00374	CcSEcCtD
Trospium—Back pain—Capecitabine—esophageal cancer	0.0029	0.00371	CcSEcCtD
Trospium—Decreased appetite—Cisplatin—esophageal cancer	0.00289	0.00369	CcSEcCtD
Trospium—Muscle spasms—Capecitabine—esophageal cancer	0.00288	0.00369	CcSEcCtD
Trospium—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00287	0.00367	CcSEcCtD
Trospium—Infestation—Methotrexate—esophageal cancer	0.00286	0.00365	CcSEcCtD
Trospium—Infestation NOS—Methotrexate—esophageal cancer	0.00286	0.00365	CcSEcCtD
Trospium—Stevens-Johnson syndrome—Methotrexate—esophageal cancer	0.00283	0.00362	CcSEcCtD
Trospium—Vision blurred—Capecitabine—esophageal cancer	0.00283	0.00361	CcSEcCtD
Trospium—Stomatitis—Methotrexate—esophageal cancer	0.00278	0.00356	CcSEcCtD
Trospium—Feeling abnormal—Cisplatin—esophageal cancer	0.00274	0.0035	CcSEcCtD
Trospium—Haematuria—Methotrexate—esophageal cancer	0.00272	0.00348	CcSEcCtD
Trospium—Syncope—Capecitabine—esophageal cancer	0.00269	0.00344	CcSEcCtD
Trospium—Palpitations—Capecitabine—esophageal cancer	0.00265	0.00339	CcSEcCtD
Trospium—Loss of consciousness—Capecitabine—esophageal cancer	0.00264	0.00337	CcSEcCtD
Trospium—Chest pain—Capecitabine—esophageal cancer	0.00255	0.00326	CcSEcCtD
Trospium—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.00254	0.00324	CcSEcCtD
Trospium—Urinary tract disorder—Methotrexate—esophageal cancer	0.00253	0.00324	CcSEcCtD
Trospium—Urethral disorder—Methotrexate—esophageal cancer	0.00251	0.00321	CcSEcCtD
Trospium—Dry mouth—Capecitabine—esophageal cancer	0.0025	0.00319	CcSEcCtD
Trospium—Visual impairment—Methotrexate—esophageal cancer	0.00247	0.00316	CcSEcCtD
Trospium—Confusional state—Capecitabine—esophageal cancer	0.00247	0.00316	CcSEcCtD
Trospium—Oedema—Capecitabine—esophageal cancer	0.00245	0.00313	CcSEcCtD
Trospium—Infection—Capecitabine—esophageal cancer	0.00243	0.00311	CcSEcCtD
Trospium—Erythema multiforme—Methotrexate—esophageal cancer	0.00242	0.0031	CcSEcCtD
Trospium—Shock—Capecitabine—esophageal cancer	0.00241	0.00308	CcSEcCtD
Trospium—Nervous system disorder—Capecitabine—esophageal cancer	0.0024	0.00307	CcSEcCtD
Trospium—Eye disorder—Methotrexate—esophageal cancer	0.0024	0.00306	CcSEcCtD
Trospium—Tachycardia—Capecitabine—esophageal cancer	0.00239	0.00305	CcSEcCtD
Trospium—Asthenia—Cisplatin—esophageal cancer	0.00238	0.00305	CcSEcCtD
Trospium—Cardiac disorder—Methotrexate—esophageal cancer	0.00238	0.00304	CcSEcCtD
Trospium—Skin disorder—Capecitabine—esophageal cancer	0.00238	0.00304	CcSEcCtD
Trospium—Hyperhidrosis—Capecitabine—esophageal cancer	0.00237	0.00303	CcSEcCtD
Trospium—Angiopathy—Methotrexate—esophageal cancer	0.00233	0.00298	CcSEcCtD
Trospium—Mediastinal disorder—Methotrexate—esophageal cancer	0.00231	0.00296	CcSEcCtD
Trospium—Malnutrition—Methotrexate—esophageal cancer	0.00223	0.00285	CcSEcCtD
Trospium—Dysgeusia—Methotrexate—esophageal cancer	0.00219	0.0028	CcSEcCtD
Trospium—Back pain—Methotrexate—esophageal cancer	0.00216	0.00276	CcSEcCtD
Trospium—Dyspepsia—Capecitabine—esophageal cancer	0.00215	0.00275	CcSEcCtD
Trospium—Decreased appetite—Capecitabine—esophageal cancer	0.00213	0.00272	CcSEcCtD
Trospium—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00211	0.0027	CcSEcCtD
Trospium—Vomiting—Cisplatin—esophageal cancer	0.00211	0.0027	CcSEcCtD
Trospium—Fatigue—Capecitabine—esophageal cancer	0.00211	0.0027	CcSEcCtD
Trospium—Vision blurred—Methotrexate—esophageal cancer	0.0021	0.00269	CcSEcCtD
Trospium—Rash—Cisplatin—esophageal cancer	0.00209	0.00268	CcSEcCtD
Trospium—Constipation—Capecitabine—esophageal cancer	0.00209	0.00268	CcSEcCtD
Trospium—Dermatitis—Cisplatin—esophageal cancer	0.00209	0.00267	CcSEcCtD
Trospium—Feeling abnormal—Capecitabine—esophageal cancer	0.00202	0.00258	CcSEcCtD
Trospium—Gastrointestinal pain—Capecitabine—esophageal cancer	0.002	0.00256	CcSEcCtD
Trospium—Nausea—Cisplatin—esophageal cancer	0.00197	0.00252	CcSEcCtD
Trospium—Urticaria—Capecitabine—esophageal cancer	0.00194	0.00249	CcSEcCtD
Trospium—Abdominal pain—Capecitabine—esophageal cancer	0.00193	0.00247	CcSEcCtD
Trospium—Chest pain—Methotrexate—esophageal cancer	0.0019	0.00243	CcSEcCtD
Trospium—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.00189	0.00241	CcSEcCtD
Trospium—Confusional state—Methotrexate—esophageal cancer	0.00184	0.00235	CcSEcCtD
Trospium—Anaphylactic shock—Methotrexate—esophageal cancer	0.00182	0.00233	CcSEcCtD
Trospium—Infection—Methotrexate—esophageal cancer	0.00181	0.00231	CcSEcCtD
Trospium—Nervous system disorder—Methotrexate—esophageal cancer	0.00179	0.00228	CcSEcCtD
Trospium—Skin disorder—Methotrexate—esophageal cancer	0.00177	0.00226	CcSEcCtD
Trospium—Hyperhidrosis—Methotrexate—esophageal cancer	0.00176	0.00225	CcSEcCtD
Trospium—Asthenia—Capecitabine—esophageal cancer	0.00176	0.00225	CcSEcCtD
Trospium—Pruritus—Capecitabine—esophageal cancer	0.00173	0.00221	CcSEcCtD
Trospium—Somnolence—Methotrexate—esophageal cancer	0.00162	0.00207	CcSEcCtD
Trospium—Dizziness—Capecitabine—esophageal cancer	0.00162	0.00207	CcSEcCtD
Trospium—Dyspepsia—Methotrexate—esophageal cancer	0.0016	0.00205	CcSEcCtD
Trospium—Decreased appetite—Methotrexate—esophageal cancer	0.00158	0.00203	CcSEcCtD
Trospium—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.00157	0.00201	CcSEcCtD
Trospium—Fatigue—Methotrexate—esophageal cancer	0.00157	0.00201	CcSEcCtD
Trospium—Vomiting—Capecitabine—esophageal cancer	0.00156	0.00199	CcSEcCtD
Trospium—Rash—Capecitabine—esophageal cancer	0.00154	0.00197	CcSEcCtD
Trospium—Dermatitis—Capecitabine—esophageal cancer	0.00154	0.00197	CcSEcCtD
Trospium—Headache—Capecitabine—esophageal cancer	0.00153	0.00196	CcSEcCtD
Trospium—Feeling abnormal—Methotrexate—esophageal cancer	0.0015	0.00192	CcSEcCtD
Trospium—Gastrointestinal pain—Methotrexate—esophageal cancer	0.00149	0.00191	CcSEcCtD
Trospium—Nausea—Capecitabine—esophageal cancer	0.00145	0.00186	CcSEcCtD
Trospium—Urticaria—Methotrexate—esophageal cancer	0.00145	0.00185	CcSEcCtD
Trospium—Abdominal pain—Methotrexate—esophageal cancer	0.00144	0.00184	CcSEcCtD
Trospium—Asthenia—Methotrexate—esophageal cancer	0.00131	0.00167	CcSEcCtD
Trospium—Pruritus—Methotrexate—esophageal cancer	0.00129	0.00165	CcSEcCtD
Trospium—Dizziness—Methotrexate—esophageal cancer	0.0012	0.00154	CcSEcCtD
Trospium—Vomiting—Methotrexate—esophageal cancer	0.00116	0.00148	CcSEcCtD
Trospium—Rash—Methotrexate—esophageal cancer	0.00115	0.00147	CcSEcCtD
Trospium—Dermatitis—Methotrexate—esophageal cancer	0.00115	0.00147	CcSEcCtD
Trospium—Headache—Methotrexate—esophageal cancer	0.00114	0.00146	CcSEcCtD
Trospium—Nausea—Methotrexate—esophageal cancer	0.00108	0.00138	CcSEcCtD
Trospium—CHRM2—GPCR ligand binding—SST—esophageal cancer	0.000391	0.00179	CbGpPWpGaD
Trospium—CHRM1—GPCR ligand binding—GHRL—esophageal cancer	0.000386	0.00177	CbGpPWpGaD
Trospium—CHRM3—GPCR ligand binding—GHRL—esophageal cancer	0.000385	0.00176	CbGpPWpGaD
Trospium—CHRM2—GPCR ligand binding—GHRL—esophageal cancer	0.000381	0.00175	CbGpPWpGaD
Trospium—CHRM3—Metabolism—SLC52A3—esophageal cancer	0.000377	0.00173	CbGpPWpGaD
Trospium—CHRM3—Metabolism—BLVRB—esophageal cancer	0.000377	0.00173	CbGpPWpGaD
Trospium—CHRM1—GPCR downstream signaling—AKAP13—esophageal cancer	0.000323	0.00148	CbGpPWpGaD
Trospium—CHRM3—GPCR downstream signaling—AKAP13—esophageal cancer	0.000322	0.00148	CbGpPWpGaD
Trospium—CHRM3—Metabolism—CA1—esophageal cancer	0.00032	0.00147	CbGpPWpGaD
Trospium—CHRM3—Metabolism—SLC10A2—esophageal cancer	0.00032	0.00147	CbGpPWpGaD
Trospium—CHRM2—GPCR downstream signaling—AKAP13—esophageal cancer	0.000319	0.00146	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—KMT2D—esophageal cancer	0.000302	0.00138	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—KMT2D—esophageal cancer	0.000301	0.00138	CbGpPWpGaD
Trospium—CHRM2—SIDS Susceptibility Pathways—EP300—esophageal cancer	0.000299	0.00137	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—KMT2D—esophageal cancer	0.000298	0.00137	CbGpPWpGaD
Trospium—CHRM1—GPCR downstream signaling—PDE4D—esophageal cancer	0.000295	0.00135	CbGpPWpGaD
Trospium—CHRM3—GPCR downstream signaling—PDE4D—esophageal cancer	0.000294	0.00135	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—AKAP13—esophageal cancer	0.000293	0.00134	CbGpPWpGaD
Trospium—CHRM3—Metabolism—CA2—esophageal cancer	0.000293	0.00134	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—AKAP13—esophageal cancer	0.000292	0.00134	CbGpPWpGaD
Trospium—CHRM2—GPCR downstream signaling—PDE4D—esophageal cancer	0.000292	0.00134	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—AKAP13—esophageal cancer	0.000289	0.00133	CbGpPWpGaD
Trospium—CHRM1—GPCR downstream signaling—GNG7—esophageal cancer	0.000281	0.00129	CbGpPWpGaD
Trospium—CHRM3—GPCR downstream signaling—GNG7—esophageal cancer	0.00028	0.00128	CbGpPWpGaD
Trospium—CHRM2—GPCR downstream signaling—GNG7—esophageal cancer	0.000277	0.00127	CbGpPWpGaD
Trospium—CHRM3—Metabolism—PLCE1—esophageal cancer	0.000272	0.00125	CbGpPWpGaD
Trospium—CHRM3—Metabolism—ADH7—esophageal cancer	0.000272	0.00125	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—ADCYAP1—esophageal cancer	0.000269	0.00123	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—PDE4D—esophageal cancer	0.000268	0.00123	CbGpPWpGaD
Trospium—CHRM1—Regulation of Actin Cytoskeleton—EGFR—esophageal cancer	0.000268	0.00123	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—ADCYAP1—esophageal cancer	0.000268	0.00123	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—PDE4D—esophageal cancer	0.000267	0.00123	CbGpPWpGaD
Trospium—CHRM3—Regulation of Actin Cytoskeleton—EGFR—esophageal cancer	0.000267	0.00123	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—ADCYAP1—esophageal cancer	0.000265	0.00122	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—PDE4D—esophageal cancer	0.000265	0.00121	CbGpPWpGaD
Trospium—CHRM2—Regulation of Actin Cytoskeleton—EGFR—esophageal cancer	0.000265	0.00121	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—GNG7—esophageal cancer	0.000255	0.00117	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—GNG7—esophageal cancer	0.000254	0.00117	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—GNG7—esophageal cancer	0.000252	0.00115	CbGpPWpGaD
Trospium—CHRM1—Circadian rythm related genes—EP300—esophageal cancer	0.000248	0.00114	CbGpPWpGaD
Trospium—CHRM1—GPCR downstream signaling—CXCL2—esophageal cancer	0.000247	0.00113	CbGpPWpGaD
Trospium—CHRM3—GPCR downstream signaling—CXCL2—esophageal cancer	0.000247	0.00113	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—WWOX—esophageal cancer	0.000246	0.00113	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—WWOX—esophageal cancer	0.000245	0.00112	CbGpPWpGaD
Trospium—CHRM2—GPCR downstream signaling—CXCL2—esophageal cancer	0.000244	0.00112	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—WWOX—esophageal cancer	0.000243	0.00111	CbGpPWpGaD
Trospium—CHRM3—Metabolism—ADH1B—esophageal cancer	0.000239	0.0011	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—FKBP1A—esophageal cancer	0.000234	0.00107	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—FKBP1A—esophageal cancer	0.000233	0.00107	CbGpPWpGaD
Trospium—CHRM1—Regulation of Actin Cytoskeleton—PIK3CA—esophageal cancer	0.000233	0.00107	CbGpPWpGaD
Trospium—CHRM3—Regulation of Actin Cytoskeleton—PIK3CA—esophageal cancer	0.000232	0.00106	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—FKBP1A—esophageal cancer	0.000231	0.00106	CbGpPWpGaD
Trospium—CHRM1—GPCR downstream signaling—ANXA1—esophageal cancer	0.00023	0.00105	CbGpPWpGaD
Trospium—CHRM2—Regulation of Actin Cytoskeleton—PIK3CA—esophageal cancer	0.00023	0.00105	CbGpPWpGaD
Trospium—CHRM3—GPCR downstream signaling—ANXA1—esophageal cancer	0.000229	0.00105	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—WIF1—esophageal cancer	0.000229	0.00105	CbGpPWpGaD
Trospium—CHRM3—Metabolism—TYMP—esophageal cancer	0.000228	0.00105	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—WIF1—esophageal cancer	0.000228	0.00104	CbGpPWpGaD
Trospium—CHRM2—GPCR downstream signaling—ANXA1—esophageal cancer	0.000227	0.00104	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—WIF1—esophageal cancer	0.000226	0.00103	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—SLC52A3—esophageal cancer	0.000225	0.00103	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—BLVRB—esophageal cancer	0.000225	0.00103	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—CXCL2—esophageal cancer	0.000225	0.00103	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—CXCL2—esophageal cancer	0.000224	0.00103	CbGpPWpGaD
Trospium—CHRM1—GPCR downstream signaling—SST—esophageal cancer	0.000224	0.00103	CbGpPWpGaD
Trospium—CHRM3—GPCR downstream signaling—SST—esophageal cancer	0.000223	0.00102	CbGpPWpGaD
Trospium—CHRM3—Metabolism—CYP26A1—esophageal cancer	0.000222	0.00102	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—CXCL2—esophageal cancer	0.000222	0.00102	CbGpPWpGaD
Trospium—CHRM2—GPCR downstream signaling—SST—esophageal cancer	0.000221	0.00101	CbGpPWpGaD
Trospium—CHRM1—GPCR downstream signaling—GHRL—esophageal cancer	0.000218	0.001	CbGpPWpGaD
Trospium—CHRM3—GPCR downstream signaling—GHRL—esophageal cancer	0.000217	0.000997	CbGpPWpGaD
Trospium—CHRM3—Metabolism—ALOX15—esophageal cancer	0.000216	0.000992	CbGpPWpGaD
Trospium—CHRM2—GPCR downstream signaling—GHRL—esophageal cancer	0.000215	0.000987	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—CSNK1A1—esophageal cancer	0.000211	0.000967	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—CSNK1A1—esophageal cancer	0.00021	0.000964	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—ANXA1—esophageal cancer	0.000209	0.000958	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—ANXA1—esophageal cancer	0.000208	0.000955	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—CSNK1A1—esophageal cancer	0.000208	0.000955	CbGpPWpGaD
Trospium—CHRM3—Metabolism—TPI1—esophageal cancer	0.000206	0.000947	CbGpPWpGaD
Trospium—CHRM3—Metabolism—GSTO1—esophageal cancer	0.000206	0.000947	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—ANXA1—esophageal cancer	0.000206	0.000946	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—SST—esophageal cancer	0.000203	0.000932	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—SST—esophageal cancer	0.000203	0.000929	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—SST—esophageal cancer	0.000201	0.00092	CbGpPWpGaD
Trospium—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—esophageal cancer	0.0002	0.000917	CbGpPWpGaD
Trospium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—esophageal cancer	0.000199	0.000914	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—GHRL—esophageal cancer	0.000198	0.000908	CbGpPWpGaD
Trospium—CHRM3—Metabolism—ALDOB—esophageal cancer	0.000198	0.000908	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—GHRL—esophageal cancer	0.000197	0.000905	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—PFN1—esophageal cancer	0.000197	0.000905	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—PFN1—esophageal cancer	0.000197	0.000902	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—GHRL—esophageal cancer	0.000196	0.000896	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—PFN1—esophageal cancer	0.000195	0.000893	CbGpPWpGaD
Trospium—CHRM1—G alpha (q) signalling events—PIK3CA—esophageal cancer	0.000194	0.00089	CbGpPWpGaD
Trospium—CHRM3—G alpha (q) signalling events—PIK3CA—esophageal cancer	0.000193	0.000887	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—CA1—esophageal cancer	0.000192	0.000879	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—SLC10A2—esophageal cancer	0.000192	0.000879	CbGpPWpGaD
Trospium—CHRM3—Metabolism—GAPDH—esophageal cancer	0.000191	0.000874	CbGpPWpGaD
Trospium—CHRM3—Metabolism—CRABP1—esophageal cancer	0.000189	0.000866	CbGpPWpGaD
Trospium—CHRM3—Metabolism—GNG7—esophageal cancer	0.00018	0.000824	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—ELMO1—esophageal cancer	0.000177	0.000813	CbGpPWpGaD
Trospium—CHRM1—Circadian rythm related genes—TP53—esophageal cancer	0.000177	0.000813	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—ELMO1—esophageal cancer	0.000177	0.00081	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—CA2—esophageal cancer	0.000175	0.000804	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—ELMO1—esophageal cancer	0.000175	0.000802	CbGpPWpGaD
Trospium—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	0.000174	0.000796	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—AKAP13—esophageal cancer	0.000173	0.000794	CbGpPWpGaD
Trospium—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	0.000173	0.000793	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—AKAP13—esophageal cancer	0.000173	0.000792	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—AKAP13—esophageal cancer	0.000171	0.000784	CbGpPWpGaD
Trospium—CHRM3—Metabolism—ALDH2—esophageal cancer	0.000168	0.000772	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—ADH7—esophageal cancer	0.000163	0.000747	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—PLCE1—esophageal cancer	0.000163	0.000747	CbGpPWpGaD
Trospium—CHRM3—Metabolism—GSTT1—esophageal cancer	0.00016	0.000734	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—HIST1H2BM—esophageal cancer	0.00016	0.000733	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000159	0.000731	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—PDE4D—esophageal cancer	0.000158	0.000726	CbGpPWpGaD
Trospium—CHRM3—Metabolism—CYP2A6—esophageal cancer	0.000158	0.000726	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—PDE4D—esophageal cancer	0.000158	0.000724	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000158	0.000724	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—PDE4D—esophageal cancer	0.000156	0.000717	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—GNG7—esophageal cancer	0.000151	0.000691	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—GNG7—esophageal cancer	0.00015	0.000689	CbGpPWpGaD
Trospium—CHRM3—Metabolism—ENO1—esophageal cancer	0.00015	0.000688	CbGpPWpGaD
Trospium—CHRM3—Metabolism—PTGS1—esophageal cancer	0.00015	0.000688	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—GNG7—esophageal cancer	0.000149	0.000682	CbGpPWpGaD
Trospium—CHRM3—Metabolism—PSME2—esophageal cancer	0.000148	0.000678	CbGpPWpGaD
Trospium—CHRM3—Metabolism—PSME1—esophageal cancer	0.000148	0.000678	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—ADH1B—esophageal cancer	0.000143	0.000655	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—XIAP—esophageal cancer	0.000141	0.000647	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—XIAP—esophageal cancer	0.000141	0.000645	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—XIAP—esophageal cancer	0.000139	0.000639	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—TYMP—esophageal cancer	0.000137	0.000626	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—CTNNA1—esophageal cancer	0.000134	0.000612	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—CTNNA1—esophageal cancer	0.000133	0.00061	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—CYP26A1—esophageal cancer	0.000133	0.000609	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—CXCL2—esophageal cancer	0.000133	0.000609	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—CXCL2—esophageal cancer	0.000132	0.000607	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—CTNNA1—esophageal cancer	0.000132	0.000604	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—CXCL2—esophageal cancer	0.000131	0.000601	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—ALOX15—esophageal cancer	0.000129	0.000593	CbGpPWpGaD
Trospium—CHRM3—Metabolism—CYP1B1—esophageal cancer	0.000128	0.000585	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—PSME2—esophageal cancer	0.000124	0.000569	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—PSME1—esophageal cancer	0.000124	0.000569	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—PSME2—esophageal cancer	0.000124	0.000567	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—PSME1—esophageal cancer	0.000124	0.000567	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—GSTO1—esophageal cancer	0.000123	0.000566	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—TPI1—esophageal cancer	0.000123	0.000566	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—ANXA1—esophageal cancer	0.000123	0.000566	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—ANXA1—esophageal cancer	0.000123	0.000564	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—PSME2—esophageal cancer	0.000122	0.000561	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—PSME1—esophageal cancer	0.000122	0.000561	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—ANXA1—esophageal cancer	0.000122	0.000559	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—SST—esophageal cancer	0.00012	0.000551	CbGpPWpGaD
Trospium—CHRM3—Metabolism—CYP19A1—esophageal cancer	0.00012	0.00055	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—SST—esophageal cancer	0.00012	0.000549	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—SST—esophageal cancer	0.000119	0.000543	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—ALDOB—esophageal cancer	0.000118	0.000543	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—GHRL—esophageal cancer	0.000117	0.000536	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—NOTCH3—esophageal cancer	0.000117	0.000536	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—GHRL—esophageal cancer	0.000117	0.000535	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—NOTCH3—esophageal cancer	0.000117	0.000535	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—GHRL—esophageal cancer	0.000115	0.00053	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—NOTCH3—esophageal cancer	0.000115	0.00053	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—FBXW7—esophageal cancer	0.000115	0.000528	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—FBXW7—esophageal cancer	0.000115	0.000526	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—GAPDH—esophageal cancer	0.000114	0.000522	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—FBXW7—esophageal cancer	0.000114	0.000521	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—CRABP1—esophageal cancer	0.000113	0.000518	CbGpPWpGaD
Trospium—CHRM3—Metabolism—HMOX1—esophageal cancer	0.000109	0.000502	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—GNG7—esophageal cancer	0.000107	0.000492	CbGpPWpGaD
Trospium—CHRM3—Metabolism—ABCB1—esophageal cancer	0.000105	0.000482	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—NOTCH2—esophageal cancer	0.000105	0.000481	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—NOTCH2—esophageal cancer	0.000105	0.00048	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—NOTCH2—esophageal cancer	0.000104	0.000475	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—ALDH2—esophageal cancer	0.000101	0.000461	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—GSTT1—esophageal cancer	9.57e-05	0.000439	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—CYP2A6—esophageal cancer	9.46e-05	0.000434	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—TGFBR2—esophageal cancer	9.31e-05	0.000427	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—TGFBR2—esophageal cancer	9.28e-05	0.000425	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—TGFBR2—esophageal cancer	9.19e-05	0.000421	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—PTGS1—esophageal cancer	8.97e-05	0.000411	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—ENO1—esophageal cancer	8.97e-05	0.000411	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—PSME2—esophageal cancer	8.84e-05	0.000405	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—PSME1—esophageal cancer	8.84e-05	0.000405	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—SMAD4—esophageal cancer	8.81e-05	0.000404	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—SMAD4—esophageal cancer	8.78e-05	0.000403	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—SMAD4—esophageal cancer	8.7e-05	0.000399	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—CYP1B1—esophageal cancer	7.63e-05	0.00035	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—HIF1A—esophageal cancer	7.21e-05	0.000331	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—HIF1A—esophageal cancer	7.19e-05	0.00033	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—CYP19A1—esophageal cancer	7.17e-05	0.000329	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—HIF1A—esophageal cancer	7.12e-05	0.000326	CbGpPWpGaD
Trospium—CHRM3—Metabolism—CREBBP—esophageal cancer	7.02e-05	0.000322	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—KDR—esophageal cancer	6.9e-05	0.000316	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—KDR—esophageal cancer	6.87e-05	0.000315	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—KDR—esophageal cancer	6.81e-05	0.000312	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—HMOX1—esophageal cancer	6.54e-05	0.0003	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—NOTCH1—esophageal cancer	6.5e-05	0.000298	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—NOTCH1—esophageal cancer	6.47e-05	0.000297	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—NOTCH1—esophageal cancer	6.41e-05	0.000294	CbGpPWpGaD
Trospium—CHRM3—Metabolism—NOS3—esophageal cancer	6.29e-05	0.000288	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—ABCB1—esophageal cancer	6.28e-05	0.000288	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—CREBBP—esophageal cancer	5.89e-05	0.00027	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—CREBBP—esophageal cancer	5.87e-05	0.000269	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—CREBBP—esophageal cancer	5.81e-05	0.000267	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—EGFR—esophageal cancer	5.79e-05	0.000265	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—EGFR—esophageal cancer	5.77e-05	0.000265	CbGpPWpGaD
Trospium—CHRM3—Metabolism—PTGS2—esophageal cancer	5.75e-05	0.000264	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—EGFR—esophageal cancer	5.71e-05	0.000262	CbGpPWpGaD
Trospium—CHRM1—GPCR downstream signaling—PIK3CA—esophageal cancer	5.53e-05	0.000254	CbGpPWpGaD
Trospium—CHRM3—GPCR downstream signaling—PIK3CA—esophageal cancer	5.51e-05	0.000253	CbGpPWpGaD
Trospium—CHRM2—GPCR downstream signaling—PIK3CA—esophageal cancer	5.46e-05	0.00025	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—NOS3—esophageal cancer	5.27e-05	0.000242	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—NOS3—esophageal cancer	5.26e-05	0.000241	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—NOS3—esophageal cancer	5.21e-05	0.000239	CbGpPWpGaD
Trospium—CHRM1—Signaling by GPCR—PIK3CA—esophageal cancer	5.02e-05	0.00023	CbGpPWpGaD
Trospium—CHRM3—Signaling by GPCR—PIK3CA—esophageal cancer	5.01e-05	0.00023	CbGpPWpGaD
Trospium—CHRM2—Signaling by GPCR—PIK3CA—esophageal cancer	4.96e-05	0.000227	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—ERBB2—esophageal cancer	4.93e-05	0.000226	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—ERBB2—esophageal cancer	4.92e-05	0.000225	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—ERBB2—esophageal cancer	4.87e-05	0.000223	CbGpPWpGaD
Trospium—CHRM3—Metabolism—EP300—esophageal cancer	4.78e-05	0.000219	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—CCND1—esophageal cancer	4.36e-05	0.0002	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—CCND1—esophageal cancer	4.34e-05	0.000199	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—CCND1—esophageal cancer	4.3e-05	0.000197	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—CDKN1A—esophageal cancer	4.22e-05	0.000193	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—CDKN1A—esophageal cancer	4.2e-05	0.000193	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—CREBBP—esophageal cancer	4.2e-05	0.000192	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—CDKN1A—esophageal cancer	4.16e-05	0.000191	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—EP300—esophageal cancer	4.01e-05	0.000184	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—EP300—esophageal cancer	4e-05	0.000183	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—EP300—esophageal cancer	3.96e-05	0.000182	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—NOS3—esophageal cancer	3.76e-05	0.000172	CbGpPWpGaD
Trospium—CHRM3—Metabolism—PIK3CA—esophageal cancer	3.54e-05	0.000162	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—MYC—esophageal cancer	3.5e-05	0.00016	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—MYC—esophageal cancer	3.48e-05	0.00016	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—MYC—esophageal cancer	3.45e-05	0.000158	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—PTGS2—esophageal cancer	3.44e-05	0.000158	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—EGFR—esophageal cancer	3.42e-05	0.000157	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—EGFR—esophageal cancer	3.41e-05	0.000156	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—EGFR—esophageal cancer	3.37e-05	0.000155	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—PIK3CA—esophageal cancer	2.97e-05	0.000136	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—PIK3CA—esophageal cancer	2.96e-05	0.000136	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—PIK3CA—esophageal cancer	2.93e-05	0.000134	CbGpPWpGaD
Trospium—CHRM1—Signaling Pathways—TP53—esophageal cancer	2.87e-05	0.000132	CbGpPWpGaD
Trospium—CHRM3—Signaling Pathways—TP53—esophageal cancer	2.86e-05	0.000131	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—EP300—esophageal cancer	2.86e-05	0.000131	CbGpPWpGaD
Trospium—CHRM2—Signaling Pathways—TP53—esophageal cancer	2.83e-05	0.00013	CbGpPWpGaD
Trospium—CYP2D6—Metabolism—PIK3CA—esophageal cancer	2.11e-05	9.7e-05	CbGpPWpGaD
